Legal News

Report shows decline in industry clinical trials initiated in UK

Published on: 24 October 2022
Published by LNB News

LNB News 24/10/2022

Document Information

Issue Date: 24 October 2022

Published Date: 24 October 2022

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Association of the British Pharmaceutical Industry (ABPI) has published a report, titled ‘Rescuing patient access to industry clinical trials in the UK’, which shows that the number of industry clinical trials started in the UK per year dropped by 41% between 2017–2021, and Phase III industry trials decreased by 48% in the same period. It also found that pharmaceutical companies are forced to place their trials in other countries due to slow NHS recruitment timelines and study set up, and patient access to industry clinical trials on the National Institute for Health and Care Research Clinical Research Network has dropped by 44% between 2017–2018 and 2021–2022. The report highlights that the UK had dropped down the global rankings for late-stage clinical research, from second to sixth in Phase II trials and fourth to tenth in Phase III trials between 2017–2021.

Popular documents